This page lists the SEC filings reported by RA Capital Management.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2008-02-14 | RA CAPITAL MANAGEMENT, LLC | RENOVIS INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2008-02-14 | RA CAPITAL MANAGEMENT, LLC | ARADIGM CORP | 7,489,810 | 13.9% | EDGAR |
| SC 13G | 2008-02-01 | RA CAPITAL MANAGEMENT, LLC | MiddleBrook Pharmaceuticals, Inc. | 3,403,467 | 6.1% | EDGAR |
| SC 13G | 2007-12-20 | RA CAPITAL MANAGEMENT, LLC | NEUROCRINE BIOSCIENCES INC | 1,955,000 | 5.1% | EDGAR |
| SC 13G | 2007-12-10 | RA CAPITAL MANAGEMENT, LLC | ROCKWELL MEDICAL TECHNOLOGIES INC | 1,366,667 | 9.9% | EDGAR |
| SC 13G | 2007-08-15 | RA CAPITAL MANAGEMENT, LLC | CURIS INC | 7,520,564 | 11.9% | EDGAR |
| SC 13G | 2007-06-20 | RA CAPITAL MANAGEMENT, LLC | AP PHARMA INC /DE/ | 2,424,242 | 8.8% | EDGAR |
| SC 13G | 2007-05-29 | RA CAPITAL MANAGEMENT, LLC | ADOLOR CORP | 2,347,795 | 5.1% | EDGAR |
| SC 13G | 2007-05-04 | RA CAPITAL MANAGEMENT, LLC | Innovive Pharmaceuticals, Inc. | 1,478,747 | 10.0% | EDGAR |
| SC 13G/A | 2007-03-28 | RA CAPITAL MANAGEMENT, LLC | ARADIGM CORP | 6,444,010 | 13.1% | EDGAR |
| SC 13G/A | 2007-03-28 | RA CAPITAL MANAGEMENT, LLC | LIPID SCIENCES INC/ | 3,713,962 | 10.0% | EDGAR |
| SC 13G | 2007-03-12 | RA CAPITAL MANAGEMENT, LLC | IOMAI CORP | 1,706,828 | 6.5% | EDGAR |
| SC 13G/A | 2007-02-14 | RA CAPITAL MANAGEMENT, LLC | GENAERA CORP | 6,328,163 | 6.0% | EDGAR |
| SC 13G/A | 2007-02-14 | RA CAPITAL MANAGEMENT, LLC | GENELABS TECHNOLOGIES INC /CA | 1,347,205 | 5.6% | EDGAR |
| SC 13G/A | 2007-02-14 | RA CAPITAL MANAGEMENT, LLC | AVIGEN INC \DE | 1,000 | 0.0% | EDGAR |
| SC 13G/A | 2007-02-14 | RA CAPITAL MANAGEMENT, LLC | Chelsea Therapeutics International, Ltd. | 1,357,802 | 6.9% | EDGAR |
| SC 13G/A | 2007-02-14 | RA CAPITAL MANAGEMENT, LLC | Cougar Biotechnology, Inc. | 526,415 | 10.0% | EDGAR |
| SC 13G | 2007-02-05 | RA CAPITAL MANAGEMENT, LLC | ARADIGM CORP | 6,355,000 | 13.0% | EDGAR |
| SC 13G | 2007-01-29 | RA CAPITAL MANAGEMENT, LLC | RENOVIS INC | 1,622,900 | 5.5% | EDGAR |
| SC 13G | 2007-01-03 | RA CAPITAL MANAGEMENT, LLC | LIPID SCIENCES INC/ | 3,763,262 | 10.2% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.